Research Highlights

An NIH grant will allow Chelsie E. Armbruster, PhD, to study pathogens than cause urinary tract infections, the most common infections worldwide and a leading cause of morbidity and health care expenditures across all ages.

New research reveals that triggering a cell’s DNA damage response could be a promising avenue for developing novel treatments against several rare but devastating viruses for which no antiviral treatments exist.

Two doctoral candidates at the Jacobs School of Medicine and Biomedical Sciences have received 2024 predoctoral fellowships with two years of funding from the American Heart Association (AHA).

One of the most dramatic success stories in modern medicine is the treatment of cystic fibrosis (CF), where therapeutic breakthroughs have dramatically reduced patients’ symptoms and increased their life expectancies.

Yijun Sun, PhD, professor of microbiology and immunology, has received two large-scale R01 grants from the National Institutes of Health to study cancer evolution and progression.